Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red blood cells.

S Peter Klinken1

  • 1Department of Biochemistry, Laboratory for Cancer Medicine, Institute for Medical Research, The University of Western Australia, Level 6, Medical Research Foundation Building-Rear, 50 Murray Street, 6000 Perth, Australia. pklinken@cyllene.uwa.edu.au

The International Journal of Biochemistry & Cell Biology
|October 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FANTOM5 CAGE profiles of human and mouse samples.

Scientific data·2017
Same author

Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells.

Science (New York, N.Y.)·2015
Same author

A promoter-level mammalian expression atlas.

Nature·2014
Same author

Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.

The Biochemical journal·2014
Same author

Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.

Blood·2013
Same author

Liar, a novel Lyn-binding nuclear/cytoplasmic shuttling protein that influences erythropoietin-induced differentiation.

Blood·2008
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Red blood cells transport oxygen and carbon dioxide throughout the body. Recombinant erythropoietin (Epo) effectively treats anemia, and gene therapy shows promise for hemoglobinopathies.

Area of Science:

  • Hematology
  • Cell Biology
  • Genetics

Background:

  • Red blood cells originate from hematopoietic stem cells and mature via erythropoietin (Epo) signaling.
  • These cells are crucial for oxygen and carbon dioxide transport in circulation.
  • Anemias, characterized by impaired gas exchange, are common red blood cell disorders.

Purpose of the Study:

  • To summarize the role of red blood cells in oxygen transport.
  • To highlight the therapeutic success of recombinant erythropoietin (Epo) in treating anemias.
  • To identify hemoglobinopathies as a key target for gene therapy.

Main Methods:

  • Review of red blood cell development and function.
  • Analysis of clinical outcomes with recombinant erythropoietin (Epo) therapy.

Related Experiment Videos

  • Assessment of gene therapy potential for single-gene hemoglobin disorders.

    • Main Results:

    • Recombinant erythropoietin (Epo) has demonstrated significant success in treating various anemias over the past 15 years.
    • Red blood cells' primary function is gas exchange, and their disorders often involve impaired capacity.
    • Single-gene disorders, specifically hemoglobinopathies, are prime candidates for future gene therapy interventions.

    Conclusions:

    • Red blood cell disorders, particularly anemias, significantly impact gas exchange.
    • Erythropoietin (Epo) therapy is a well-established treatment for anemia.
    • Gene therapy presents a promising future direction for treating inherited hemoglobinopathies.